Cargando…

Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in rats.

In vitro and in vivo studies have suggested synergistic anti-tumour activity of combined hyperthermia and tumour necrosis factor alpha (TNF-alpha). However, some studies indicated an increased systemic toxicity of TNF by additional hyperthermia. The aim of this study was to obtain starting dosages f...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Zee, J., van den Aardweg, G. J., van Rhoon, G. C., van den Berg, A. P., de Wit, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033841/ https://www.ncbi.nlm.nih.gov/pubmed/7779705

Ejemplares similares

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
por: de Wilt, J H W, et al.
Publicado: (2000)

Effect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumours.
por: van de Weil, P. A., et al.
Publicado: (1990)

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
por: Wilt, J H W de, et al.
Publicado: (1999)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions
por: de Wilt, J H W, et al.
Publicado: (2000)

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996)

Metabolic effects of tumour necrosis factor alpha in NMRI mice.
por: Mahony, S. M., et al.
Publicado: (1990)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.
por: Shah, P., et al.
Publicado: (1989)

Molecular prognostic factors in small-intestinal neuroendocrine tumours
por: Samsom, K G, et al.
Publicado: (2019)

Reactions of the tumour bed to lethally irradiated tumour cells, and the Révész effect.
por: van den Brenk, H. A., et al.
Publicado: (1977)

Masson’s tumour of the kidney
por: Van den Bogaert, S., et al.
Publicado: (2015)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
por: Tse, Brian W. C., et al.
Publicado: (2012)

Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
por: DAVIDSON, Linda, et al.
Publicado: (2022)

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022)

Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast.
por: Pusztai, L., et al.
Publicado: (1994)

Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha).
por: Simonitsch, I., et al.
Publicado: (1998)

Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study
por: Michielsens, Celia A J, et al.
Publicado: (2021)

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
por: Cao, Z, et al.
Publicado: (1999)

In vivo targets of recombinant human tumour necrosis factor-alpha: blood flow, oxygen consumption and growth of isotransplanted rat tumours.
por: Kallinowski, F., et al.
Publicado: (1989)

Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha
por: Stanilov, Noyko, et al.
Publicado: (2014)

Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
por: Ruder, Barbara, et al.
Publicado: (2019)

Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1995)

The relationship between sunitinib exposure and both efficacy and toxicity in real‐world patients with renal cell carcinoma and gastrointestinal stromal tumour
por: Westerdijk, Kim, et al.
Publicado: (2020)

Rapid and accurate measurement of growth of solid tumours and changes in the tumour bed in the rat by the technique of volumetric displacement.
por: Van Den Brenk, H. A., et al.
Publicado: (1977)

Effect of toxic thioureas on resistance of rats to growth in the lungs of intravenously and intratracheally seeded tumour cells.
por: van den Brenk, H. A., et al.
Publicado: (1978)

Evaluation of anti-tumour properties of two depsidones – Unguinol and Aspergillusidone D – in triple-negative MDA-MB-231 breast tumour cells
por: Zwartsen, A., et al.
Publicado: (2019)

Proceedings: Synergism between the anti-tumour agent cis platinum (II) diamminedichloride and caffeine: toxicological and molecular studies.
por: van den Berg, H. W., et al.
Publicado: (1975)

Inhibition of tumour necrosis factor alpha production by activated T cells of rheumatoid arthritis patients by novel anti-folate drugs: an ex vivo pilot study
por: van der Heijden, JW, et al.
Publicado: (2005)

Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?
por: Giraud, Eline L., et al.
Publicado: (2023)

Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade
por: Kooyker, Arthur I, et al.
Publicado: (2019)

The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoids
por: Cecilio, C. A., et al.
Publicado: (1997)

Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus.
por: Torzecka, Jolanta Dorota, et al.
Publicado: (2003)

The promoting effect of tumour necrosis factor alpha in radiation-induced cell transformation.
por: Guo, R. F., et al.
Publicado: (1998)

Opioid receptor expression on neutrophils: effect of tumour necrosis factor alpha treatment
por: Schmidt, A, et al.
Publicado: (2007)

Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis
por: Neniskyte, Urte, et al.
Publicado: (2014)

Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma
por: Brierly, Gary, et al.
Publicado: (2023)

A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix
por: Wit, R de, et al.
Publicado: (1999)

Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.
por: Pullyblank, A. M., et al.
Publicado: (1995)

The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation
por: Inglis, Julia J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_6i4v6dpho5sr7jhbampkau4ks4